324 results on '"Seror, Olivier"'
Search Results
2. Patch-based field-of-view matching in multi-modal images for electroporation-based ablations
3. Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab
4. Early results of a French care-related adverse events database in radiology
5. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments.
6. Non-invasive diagnosis and follow-up of primary malignant liver tumours
7. Imaging and histological features of tumor biopsy sample predict aggressive intrasegmental recurrence of hepatocellular carcinoma after radiofrequency ablation
8. OS-110 ARMCENVIN: multibipolar radiofrequency ablation of HCC using intratumourous versus extratumourous “no-touch” techniques. French multicentric randomized controlled trial (NCT 01008657)
9. THU-459-YI Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma: a multicentric retrospective study
10. OS-077 Added value of a combination of positron emission tomography with 18F-FDG and 18 F-Fluorocholine for staging optimization and treatment modification in patients with hepatocellular carcinoma: the prospective multicentric PET HCC01 study
11. THU-487-YI Upfront multi-bipolar radiofrequency ablation for hepatocarcinoma in transplant-eligible cirrhotic patients with salvage transplantation in case of recurrence
12. Use of Virtual Target Fluoroscopic Display of Three-Dimensional CO2 Wedged Hepatic Vein Portography for TIPS Placement
13. Cost-Utility Analysis of Transarterial Radioembolization With Yttrium-90 Resin Microspheres Compared With Sorafenib in Locally Advanced and Inoperable Hepatocellular Carcinoma
14. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area
15. No-Touch Multi-bipolar Radiofrequency Ablation for the Treatment of Subcapsular Hepatocellular Carcinoma ≤ 5 cm Not Puncturable via the Non-tumorous Liver Parenchyma
16. Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis
17. Long‐term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma.
18. Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab
19. Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma
20. Liver Resection for Solitary Transplantable Hepatocellular Carcinoma: The Role of AFP-Score
21. Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab.
22. A proposal for a useful algorithm to diagnose small hepatocellular carcinoma on MRI
23. The CRP level and STATE score predict survival in cirrhotic patients with hepatocellular carcinoma treated by transarterial embolization
24. Supplementary Figures 1 - 2 from Identification of Serum Proton NMR Metabolomic Fingerprints Associated with Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis
25. Supplementary Figure 1 from Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis
26. Data from Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis
27. Supplementary Table 1 from Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis
28. Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma
29. Histopathologic Comparison of Monopolar versus No-Touch Multipolar Radiofrequency Ablation to Treat Hepatocellular Carcinoma within Milan Criteria
30. Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress
31. Percutaneous Treatment of Localized Infiltrative Hepatocellular Carcinoma Developing on Cirrhosis
32. Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization
33. Validation of the continuous controlled attenuation parameter (CAPc) using the MRI-PDFF as reference
34. EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice
35. A tailored approach for the treatment of hepatocellular carcinoma within Milan criteria developed on advanced fibrosis/cirrhosis by multibipolar radiofrequency ablation or liver resection
36. Automated needle localisation for electric field computation during an electroporation ablation
37. Impact of Extended Use of Ablation Techniques in Cirrhotic Patients with Hepatocellular Carcinoma: A Cost-Effectiveness Analysis
38. Ablation tumorale hépatique: jusqu'où aller ?
39. No touch radiofrequency ablation for hepatocellular carcinoma: a conceptual approach rather than an iron law
40. Percutaneous treatments of hepatocellular carcinoma: Improving efficacy, applicability and extending ablation criteria
41. Percutaneous ablation for locally advanced hepatocellular carcinoma with tumor portal invasion
42. Is segmental transarterial yttrium 90 radiation a curative option for solitary hepatocellular carcinoma ≤5 cm?
43. Health-related quality of life in locally advanced hepatocellular carcinoma treated by either radioembolisation or sorafenib (SARAH trial)
44. Cost-Utility Analysis of Transarterial Radioembolization With Yttrium-90 Resin Microspheres Compared With Sorafenib in Locally Advanced and Inoperable Hepatocellular Carcinoma
45. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF PRIMARY MALIGNANT LIVER TUMOURS
46. Radiofrequency Ablation with Internally Cooled versus Perfused Electrodes for the Treatment of Small Hepatocellular Carcinoma in Patients with Cirrhosis
47. Real-time monitoring of radiofrequency ablation of liver tumors using thermal-dose calculation by MR temperature imaging: initial results in nine patients, including follow-up
48. Real time monitoring of radiofrequency ablation based on MR thermometry and thermal dose in the pig liver in vivo
49. RADIOLOGICAL AND PATHOLOGICAL RESPONSE TO NEOADJUVANT NIVOLUMAB IN PATIENTS WITH BCLC A HCC TREATED BY CURATIVE PERCUTANEOUS IRREVERSIBLE ELECTROPORATION: PRELIMINARY REPORT FROM THE FRENCH MULTICENTRE PHASE 2 NIVOLEP TRIAL
50. Quantitative magnetic resonance temperature mapping for real-time monitoring of radiofrequency ablation of the liver: an ex vivo study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.